Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor

NEXT STORY
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
PREV STORY
The Need for Medicare to Pay for Telehealth-focused Communication Platforms
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference

author_avatar
NASDAQ Market News

Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer

author_avatar
NASDAQ Market News

Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

author_avatar
NASDAQ Market News